| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancements in therapeutic peptides: Shaping the future of cancer treatment
|
Chen, Xiaojie
|
|
|
1879 |
6 |
p.
|
artikel
|
| 2 |
Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review
|
Y, Krithicaa Narayanaa
|
|
|
1879 |
6 |
p.
|
artikel
|
| 3 |
Advances of SS18-SSX fusion gene in synovial sarcoma: Emerging novel functions and therapeutic potentials
|
Ren, Chongmin
|
|
|
1879 |
6 |
p.
|
artikel
|
| 4 |
An updated outlook on autophagy mechanism and how it supports acute myeloid leukemia maintenance
|
Santos de Macedo, Brunno Gilberto
|
|
|
1879 |
6 |
p.
|
artikel
|
| 5 |
Belling the “cat”: Wnt/β-catenin signaling and its significance in future cancer therapies
|
Goyal, Akansha
|
|
|
1879 |
6 |
p.
|
artikel
|
| 6 |
Biomarkers in high grade serous ovarian cancer
|
Bates, Mark
|
|
|
1879 |
6 |
p.
|
artikel
|
| 7 |
Biomechanical properties of laminins and their impact on cancer progression
|
Nonnast, Elena
|
|
|
1879 |
6 |
p.
|
artikel
|
| 8 |
CAR-T cell therapy: Challenge and opportunity for effective treatment of small cell lung cancer
|
Yin, Limei
|
|
|
1879 |
6 |
p.
|
artikel
|
| 9 |
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy
|
Feng, Dandan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 10 |
Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment
|
Hou, Yifan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 11 |
Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies
|
Liu, Ying
|
|
|
1879 |
6 |
p.
|
artikel
|
| 12 |
Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance
|
Panda, Sameer Kumar
|
|
|
1879 |
6 |
p.
|
artikel
|
| 13 |
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications
|
Wang, Yuanyuan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 14 |
Developing pioneering pharmacological strategies with CRISPR/Cas9 library screening to overcome cancer drug resistance
|
He, Yu
|
|
|
1879 |
6 |
p.
|
artikel
|
| 15 |
Dual roles of human endogenous retroviruses in cancer progression and antitumor immune response
|
Yang, Yang
|
|
|
1879 |
6 |
p.
|
artikel
|
| 16 |
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer
|
Bi, Ruomeng
|
|
|
1879 |
6 |
p.
|
artikel
|
| 17 |
Epigenetic regulation of TGF-β and vice versa in cancers – A review on recent developments
|
Naik, Ankit
|
|
|
1879 |
6 |
p.
|
artikel
|
| 18 |
Epstein Barr virus: A cellular hijacker in cancer
|
Alsaadawe, Moyed
|
|
|
1879 |
6 |
p.
|
artikel
|
| 19 |
Erythroid progenitor cell modulates cancer immunity: Insights and implications
|
Mo, Wen-Tao
|
|
|
1879 |
6 |
p.
|
artikel
|
| 20 |
Exosomal non-coding RNAs (ncRNAs) as potential biomarkers in tumor early diagnosis
|
Chang, Jingyue
|
|
|
1879 |
6 |
p.
|
artikel
|
| 21 |
Glutaminase 2 as a therapeutic target in glioblastoma
|
Veeramachaneni, Rithvik K.
|
|
|
1879 |
6 |
p.
|
artikel
|
| 22 |
Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation
|
Qian, Wen-Jing
|
|
|
1879 |
6 |
p.
|
artikel
|
| 23 |
Matrisomics: Beyond the extracellular matrix for unveiling tumor microenvironment
|
Hong, Jiwon
|
|
|
1879 |
6 |
p.
|
artikel
|
| 24 |
Mechanisms of cancer cachexia and targeted therapeutic strategies
|
Li, Long
|
|
|
1879 |
6 |
p.
|
artikel
|
| 25 |
Methyltransferases in cancer drug resistance: Unlocking the potential of targeting SMYD3 to sensitize cancer cells
|
Sanese, Paola
|
|
|
1879 |
6 |
p.
|
artikel
|
| 26 |
Mitochondrial RNA methylation in cancer
|
Tan, Luyi
|
|
|
1879 |
6 |
p.
|
artikel
|
| 27 |
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids
|
Guo, Zikai
|
|
|
1879 |
6 |
p.
|
artikel
|
| 28 |
Multifaceted roles of neutrophils in tumor microenvironment
|
Pan, Xueyin
|
|
|
1879 |
6 |
p.
|
artikel
|
| 29 |
New insight into the role of SMAD4 mutation/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas
|
Yao, Hongjuan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 30 |
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
|
Zhao, Yutong
|
|
|
1879 |
6 |
p.
|
artikel
|
| 31 |
Perioperative immunotherapy for patients with EGFR mutant non-small cell lung cancer: Unexpected potential benefits
|
Teng, Feifei
|
|
|
1879 |
6 |
p.
|
artikel
|
| 32 |
Phase separation in DNA damage response: New insights into cancer development and therapy
|
Li, Lingwei
|
|
|
1879 |
6 |
p.
|
artikel
|
| 33 |
Prospects of nano-theranostic approaches against breast and cervical cancer
|
Ria, Tasnim
|
|
|
1879 |
6 |
p.
|
artikel
|
| 34 |
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma
|
Li, Danyang
|
|
|
1879 |
6 |
p.
|
artikel
|
| 35 |
RNF43 and ZNRF3: Versatile regulators at the membrane and their role in cancer
|
Li, Shanshan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 36 |
Roles of K(H)SRP in modulating gene transcription throughout cancer progression: Insights from cellular studies to clinical perspectives
|
Yang, Yi-Chieh
|
|
|
1879 |
6 |
p.
|
artikel
|
| 37 |
Roles of miRNAs in regulating ovarian cancer stemness
|
Chong, Zhi-Xiong
|
|
|
1879 |
6 |
p.
|
artikel
|
| 38 |
ROS: A “booster” for chronic inflammation and tumor metastasis
|
Chen, Anqi
|
|
|
1879 |
6 |
p.
|
artikel
|
| 39 |
Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy
|
Shi, Dandan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 40 |
Targeting autophagy in urological system cancers: From underlying mechanisms to therapeutic implications
|
Yuan, Ziyue
|
|
|
1879 |
6 |
p.
|
artikel
|
| 41 |
Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence
|
Moosavi, Fatemeh
|
|
|
1879 |
6 |
p.
|
artikel
|
| 42 |
Targeting extracellular matrix interaction in gastrointestinal cancer: Immune modulation, metabolic reprogramming, and therapeutic strategies
|
Li, Jiyifan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 43 |
The curious case of type I interferon signaling in cancer
|
Chhipa, Abu Sufiyan
|
|
|
1879 |
6 |
p.
|
artikel
|
| 44 |
The emerging role of extracellular vesicles and particles in prostate cancer diagnosis, and risk stratification
|
Wang, Qi
|
|
|
1879 |
6 |
p.
|
artikel
|
| 45 |
The interplay between microbiome and host factors in pathogenesis and therapy of head and neck cancer
|
Raudenská, Martina
|
|
|
1879 |
6 |
p.
|
artikel
|
| 46 |
The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies
|
Chen, Engeng
|
|
|
1879 |
6 |
p.
|
artikel
|
| 47 |
The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives
|
Xia, Bing
|
|
|
1879 |
6 |
p.
|
artikel
|
| 48 |
The potential of TRP channels as new prognostic and therapeutic targets against prostate cancer progression
|
Chinigò, Giorgia
|
|
|
1879 |
6 |
p.
|
artikel
|
| 49 |
The role of ferroptosis resistance in lymph-associated tumour metastasis
|
Li, Xiaoyu
|
|
|
1879 |
6 |
p.
|
artikel
|
| 50 |
The tumor microenvironment's gambit: Exosomal pawns on the board of head and neck cancer
|
Mohamadi, Solmaz
|
|
|
1879 |
6 |
p.
|
artikel
|
| 51 |
Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors
|
Jiang, Jianyun
|
|
|
1879 |
6 |
p.
|
artikel
|
| 52 |
Unveiling Cuproptosis: Mechanistic insights, roles, and leading advances in oncology
|
Zhang, Limei
|
|
|
1879 |
6 |
p.
|
artikel
|
| 53 |
War or peace: Viruses and metastasis
|
Bayat, Mobina
|
|
|
1879 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving